Your browser doesn't support javascript.
loading
Efficacy and safety of brodalumab in patients with psoriasis who had inadequate responses to ustekinumab: subgroup analysis of two randomized phase III trials.
Langley, R G; Armstrong, A W; Lebwohl, M G; Blauvelt, A; Hsu, S; Tyring, S; Rastogi, S; Pillai, R; Israel, R.
Afiliação
  • Langley RG; Dalhousie University, Halifax, NS, Canada.
  • Armstrong AW; University of Southern California, Los Angeles, CA, U.S.A.
  • Lebwohl MG; Icahn School of Medicine at Mount Sinai, New York, NY, U.S.A.
  • Blauvelt A; Oregon Medical Research Center, Portland, OR, U.S.A.
  • Hsu S; Temple University School of Medicine, Philadelphia, PA, U.S.A.
  • Tyring S; University of Texas Health Science Center, Houston, TX, U.S.A.
  • Rastogi S; Ortho Dermatologics, Bridgewater, NJ, U.S.A.
  • Pillai R; Dow Pharmaceutical Sciences, Petaluma, CA, U.S.A.
  • Israel R; Valeant Pharmaceuticals North America LLC, Bridgewater, NJ, U.S.A.
Br J Dermatol ; 180(2): 306-314, 2019 02.
Article em En | MEDLINE | ID: mdl-30328108
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Fármacos Dermatológicos / Anticorpos Monoclonais Humanizados / Ustekinumab Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Dermatol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Fármacos Dermatológicos / Anticorpos Monoclonais Humanizados / Ustekinumab Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Dermatol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá